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Comparisons between venoms from snakes kept under captivity or collected at the natural environment
are of fundamental importance in order to obtain effective antivenoms to treat human victims of
snakebites. In this study, we compared composition and biological activities of Bothrops atrox venom
from snakes collected at Tapajos National Forest (Para State, Brazil) or maintained for more than 10 years
under captivity at Instituto Butantan herpetarium after have been collected mostly at Maranh~ao State,
Brazil. Venoms from captive or wild snakes were similar except for small quantitative differences
detected in peaks correspondent to phospholipases A2 (PLA2), snake venom metalloproteinases (SVMP)
class PI and serine proteinases (SVSP), which did not correlate with ﬁbrinolytic and coagulant activities
(induced by PI-SVMPs and SVSPs). In both pools, the major toxic component corresponded to PIII-SVMPs,
which were isolated and characterized. The characterization by mass spectrometry of both samples
identiﬁed peptides that matched with a single PIII-SVMP cDNA characterized by transcriptomics, named
Batroxrhagin. Sequence alignments show a strong similarity between Batroxrhagin and Jararhagin (96%).
Batroxrhagin samples isolated from venoms of wild or captive snakes were not pro-coagulant, but
inhibited collagen-induced platelet-aggregation, and induced hemorrhage and ﬁbrin lysis with similar
doses. Results suggest that in spite of environmental differences, venom variability was detected only
among the less abundant components. In opposition, the most abundant toxin, which is a PIII-SVMP
related to the key effects of the venom, is structurally conserved in the venoms. This observation is
relevant for explaining the efﬁcacy of antivenoms produced with venoms from captive snakes in human
accidents inﬂicted at distinct natural environments.
© 2015 Elsevier B.V. and Societe Française de Biochimie et Biologie Moleculaire (SFBBM). All rights
reserved.1. Introduction
Some species of advanced snakes have a special mechanism foreinase; SVSP, snake venom
Moura-da-Silva).
de Biochimie et Biologie Moleculinjection of venom into prey [1] which evolved in conjunctionwith
the venom gland serous cells from the posterior oral gland [2]. The
appearance of this sophisticated system occurred in parallel to the
evolution of lethal toxins produced by the venom gland that pro-
vided to snakes a great advantage in the evolutionary process [3].
These toxins are directed to important physiological targets of
mammals and invertebrates, mainly to the nervous system and
components responsible for the control of hemostasis, playingaire (SFBBM). All rights reserved.
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high degree of venom variation is observed at different situations
and it is assumed that it enhances the ability of venomous snakes to
adapt to different ecological niches [3,5]. Venom variability can be
observed between different species but also at intraspeciﬁc level,
represented by ontogenetic variation [6e8], related to sex [9] or
according to geographic distribution [10]. Although genetic selec-
tion mechanisms may be considered as a key of intraspeciﬁc vari-
ability [11], environmental factors such as the diet used by snakes
can inﬂuence the relative abundance of different classes of toxins in
adults [5,12]. Multiple levels of gene expression regulation are
responsible for generating variation in venom composition [13]. As
a consequence for human envenomings, venom variation may
result in signiﬁcant differences in the symptoms arising from snake
bites and can also undermine the efﬁcacy of the antivenom that
may have reduced potential to neutralize such a variety of different
toxins.
Bothrops atrox is considered the main cause of snakebite in the
Amazon [14]. Variability in venom composition of B. atrox from
different locations of the Amazon has been reported evidencing the
signiﬁcant intraspeciﬁc venom variation within this species
[15e17]. Venoms from snakes collected in Colombia and Venezuela
showed a phenotype with ontogenetic proﬁle, with PI-SVMPs and
PLA2s representing the most abundant toxins. In opposition, in
venoms from snakes collected in Brazil, Ecuador and Peru, PIII-
SVMPs were the most abundant toxin, corresponding to the
paedomorphic phenotype [15,16,18]. In Brazilian Amazon, PIII-
SVMPs were certainly the major toxins with relative concentra-
tions in venoms ranging around 50% both in proteomic or tran-
scriptomics studies [15,19,20].
The abundance of PIII-SVMPs in B. atrox venom is strongly
correlated with the symptoms of human envenomings by this
species [21]. Venom metalloproteinases, particularly PIII-SVMPs,
are responsible for the local and systemic hemorrhage and are
also involved in the local lesions due to their pro-inﬂammatory
action or the ischemia at the site of the bite which arises from
the reduction of blood supply following the damage of microvas-
culature [22,23]. Fortunately, PIII-SVMPs are highly immunogenic
and are the predominant antigens recognized by commercial
antivenoms for Bothrops snakes [20]. However, sequence and
functional variability within PIII-SVMPs have been reported and
may compromise antigen neutralization. Bernardoni and col-
leagues [24] analyzed different functional forms of Bothrops neu-
wiedi SVMPs and demonstrated selectivity for different targets in
the hemostatic system, affecting distinct mechanisms of coagula-
tion in humans, rodents and birds. In this regard, most of the
studies relating intraspeciﬁc variability are focused in proteomics
data and do not include functional variability within the same toxin
group. Thus, a comprehensive evaluation of venom composition
and biological activities is extremely important for the develop-
ment of effective antivenom.
In this context, an additional problem that must be evaluated is
if the venom obtained from snakes kept under captivity by several
generations (which are used for antivenom production) resembles
the venom from snakes collected in the wild. This aspect was
focused in this study. Venom from snakes collected mostly at
Maranh~ao State, Brazil, and kept at Instituto Butantan herpetarium
for more than ten years was compared to the venom obtained
immediately after snake collection at Tapajos National Forest, Para
State, Brazil. Venom composition analysis and characterization of
major toxic activities were carried out followed by puriﬁcation and
functional and structural characterization of PIII-SVMPs from both
sources. Our results strongly suggest that venom variability is
almost restricted to the less abundant toxins and support a com-
plete conservation of PIII-SVMPswhen snakes are introduced to thecontrolled environment. This observation leads to important con-
clusions that validate the use of snakes maintained under captivity
for antivenom production that will be used in accidents occurring
in different geographical areas.
2. Material and methods
2.1. Venom
Venom pools were obtained from wild B. atrox snakes (8 adult
specimens, 2 male, 4 female and 2 with undetermined sex)
immediately after their collection at Tapajos National Forest (GPS:
S0303.0350 W05458.1780 and S0310014.4100 W05459023.1300),
Para state, Brazil, under SISBio license 32098-1. B. atrox venomwas
also obtained from Instituto Butantan venom stock, which is
extracted from B. atrox maintained under captivity at Herpetology
laboratory. Instituto Butantan B. atrox colony is composed by 45
adult B. atrox snakes, from both sexes, collected in distinct States of
the Brazilian Amazon (4 in Amazonas, 2 in Para, 2 in Rondo^nia, 1 in
Acre, 26 at Maranh~ao States and 10 of siblings from Amazonas and
Maranh~ao breedings). Snakes were bred and maintained for more
than 10 years under captivity under controlled light and tempera-
ture and fed with rodents. After extraction, individual venom
samples were pooled, lyophilized and stored at 20 C. Before use,
venom pools were resuspended in PBS solution to the appropriate
concentration, which was measured by Bradford assay [25] using
BSA as internal reference.
2.2. Animals
Swiss mice of both sexes (18e20 g body weight) were obtained
from Instituto Butantan animal house. The procedures used during
the experiments were approved by the Animal Ethical Use Com-
mittees of the Universidade Federal do Oeste do Para (protocol n
09.002/12) and Instituto Butantan (protocol n 1270/14).
2.3. Venom composition
Venom samples (2 mg) dissolved in 500 mL 0.1% triﬂuoroacetic
acid (TFA)were fractionated on a reverse-phase column (Column C-
18 Vydac, 10 um, 4.6 mm id  250 mm) in high-performance liquid
chromatography-HPLC (Shimadzu, Japan), as previously described
[20]. The parameters for elution were 2 mL/min ﬂow, detection
UV214nm and gradient of 0.1% TFA in water (solution A) or in
acetonitrile (solution B) as follows: 5% B for 5 min, followed by
5e15% B over 10min,15e45% B over 60min, 45e70% B over 10min,
70e100% B over 5 min and 100% B over 10 min. The elution proﬁles
of venoms from snakes from the captive and natural environment
were visually compared. The protein identiﬁcation in each chro-
matographic fractionwas inferred from previous proteomic studies
with the same venom [15,20].
2.4. Puriﬁcation of PIII-class SVMPs
The venoms were ﬁrstly fractionated by hydrophobic interac-
tion followed by anion exchange chromatographies in a fast protein
liquid chromatography-FPLC (GE Healthcare, AKTA explorer 10S)
using a similar protocol than described for the puriﬁcation of jar-
arhagin, a PIII-SVMP from Bothrops jararaca venom [26,27]. Brieﬂy,
venom samples of approximately 80 mg were dissolved in 2 mL of
Buffer A (1.2 M ammonium sulfate, 1 mM CaCl2 20 mM Tris/HCl
buffer, pH 7.4), centrifuged at 13,780 g for 10 min and the super-
natant loaded onto a Hitrap Phenyl FF low sub (5 mL 1.6  2.5 cm,
GE Healthcare, USA) column. Elution was carried out with a linear
gradient of 80 mL of ammonium sulfate from 1.2 to 0 M, at a ﬂow
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hemorrhagic activity were dialyzed against 20 mM Tris/HCl buffer
(pH 6.8) containing 1 mM CaCl2 and loaded onto a Mono Q 5/50 GL
(1 mL 5  50 mm, GE Healthcare, USA) column in the same buffer.
Elution of bound proteins was achieved with a gradient of 60 mL of
NaCl from 0 to 1 M as follows: 0% NaCl for 10 min, followed by
0e25% NaCl over 40 min, 25e100% NaCl over 5 min and 100% NaCl
over 5min, at a ﬂow rate 1mL/min and detection UV280nm. Selected
fractions were kept frozen at 80 C until use.
2.5. mRNA identiﬁcation
Total RNA from the venom glands of ﬁve specimens of B. atrox
was extracted with TRIZOL Reagent (Life Technologies) and mRNA
was isolated with Dynabeads® mRNA DIRECT kit (Life Technolo-
gies). Each mRNA sample was quantiﬁed by Quant-iT™ RiboGreen®
RNA reagent and Kit (Life Technologies) and used to generate in-
dividual cDNA libraries with Illumina TruSeq RNA Sample Prep Kit.
The libraries were sequenced on an Illumina HiSeq 1500 system, in
Rapid Run mode, generating paired end reads of 150 bp. All se-
quences were processed for removing adaptors and low quality
ends and were further assembled with Trinity-2.0.6 software [28]
at default parameters. Reads from all ﬁve specimens were com-
bined, and the minimum sequence length in the assembly was set
to 350 bp. The complete transcriptomic analyzes of these samples
are under development and will be published elsewhere (Ama-
zonas et al., unpublished data). The raw sequence data is available
on GenBank SRA database under accession number (SRA database
SRP056745).
For the identiﬁcation of the mRNA corresponding to the venom
protein investigated in this work, Trinity contigs were subjected to
a BlastX search against a compiled set of snake toxins downloaded
from GenBank and UniProt databases, and those showing some
degree of similarity were separated in a subset. The translated
amino acid sequences of this subset were used as references for the
MS/MS analysis described below. Contigs showing signiﬁcant
match to the MS/MS proﬁle of the isolated protein were re-
inspected and the sequence reads remapped to correct and
extend the original contig sequence. A ﬁnal sequence containing
the 50 and 30 UTR regions of one PIII-SVMP transcript corresponding
to the isolated protein from the venom was obtained, annotated
and deposited in the GenBank as BATXSVMPIII with the accession
number KR632593.
2.6. Protein identiﬁcation
Isolated proteins were analyzed by 12.5% SDS-PAGE method as
described [29], under non-reducing or reducing conditions (treated
with 9.3% of Dithiothreitol). The gel was stained with 0.1% Coo-
massie Brilliant Blue R-250. The molecular mass standards (GE
Healthcare, USA) consisted of the following: phosphorylase b
(97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa),
carbonic anhydrase (30 kDa), trypsin inhibitor (21.1 kDa) and a-
lactalbumin (14.4 kDa).
Identiﬁcation of the proteins was performed by liquid chroma-
tography coupled to mass spectrometry (LC-MS/MS). After elec-
trophoresis protein bands were excised, destained and in gel
digested with trypsin as previously described [30]. Tryptic peptides
were resuspended in 15 mL formic acid (0.1%) and for the mass
spectrometric analysis 5 mL were submitted to reversed-phase
chromatography in a 5 cm column packed with 10 mm C18 resin
in tandem with a 10 cm column packed with 5 mm C18 resin at a
ﬂow rate of 200 nL/min in an Easy-nLC II (Thermo Scientiﬁc). The
elution gradient was 5e40% acetonitrile in 0.1% formic acid over
40 min. The eluate was applied to an LTQ OrbitrapVelos (ThermoScientiﬁc) by an electrospray nano-ﬂow interface with 2.0 kV on
the capillary. For the MS, the spectrometer was operated in positive
mode, and spectra were acquired in the m/z range of 200e2000
and resolution R ¼ 30,000. The top 10 method was used to proceed
with collision-induced dissociation. For the MS2 the following pa-
rameters were used: dynamic exclusion duration of 15 s; repeat
duration of 30 s; exclusion list size of 500. Resulting fragment
spectra were searched using Mascot (version 2.4.1; Matrix Science)
against a dataset of proteins predicted from the transcriptome of
the venom glands of ﬁve B. atrox specimens, with a peptide mass
tolerance of 10 ppm and fragment mass tolerance of 0.5 Da.
Iodoacetamide derivative of cysteine and oxidation of methionine
were speciﬁed in MASCOT as ﬁxed and variable modiﬁcations,
respectively.
2.7. Autolysis of SVMPs
Autolysis of isolated SVMPs was evaluated according to the
methodology described by Moura-da-Silva et al. [27]. The samples
were incubated at 37 C in concentrations of 0.5 mg/mL in 20 mM
Tris/HCl buffer, pH 6.8, containing 1 mM CaCl2, for 72 h. Aliquots
were withdrawn at different time intervals and the reaction was
terminated by addition of SDS-PAGE sample buffer, with or without
reducing agent (DTT 9.3%). To evaluate the products of autolysis,
aliquots were analyzed by SDS-PAGE as described above.
2.8. Hemorrhagic activity
The hemorrhagic activity was based on themethod described by
Kondo et al. [31] modiﬁed by Gutierrez et al. [32]. Venom or iso-
lated SVMPs were diluted to different concentrations in 50 mL of
PBS and injected by intradermal route into the dorsal skin of mice.
After 3 h, the animals were euthanized in a CO2 chamber, and the
dorsal skin was removed, digitalized and saved in RGB format
ﬁles for processing in a Matlab script [33] using [34] procedure.
The different components of the image were selected using a
threshold device [35] and a morphological gradient processor to
obtain the hemorrhagic halos. The hemorrhagic area (cm2) was
calculated according to [36]. The minimum hemorrhagic dose
(MHD) was as the amount in mg that produced hemorrhages with a
mean diameter of 10mm after 3 h. Groups of 4 animals were tested,
and in a control group animals were injected with PBS only. Results
are expressed as mean ± SD.
2.9. Myotoxic activity
For determination of myotoxic activity, venom samples of 50
and 100 mg in 50 mL of PBS were injected intramuscularly into the
gastrocnemius muscle of Swiss mice. After 3 h, the animals were
bled via ophthalmic plexus and the sera were assayed for crea-
tineekinase activity with a commercial kit CK-UV (Bioclin), ac-
cording to the manufacturer's instructions. Groups of 4 animals
were tested and compared to controls groups of animals were
injected with PBS or with 50 mg of venom from Bothrops jarar-
acussu. Results are expressed as mean ± SD.
2.10. Fibrinolytic activity
Fibrinolytic activity was based on the method described by
Jespersen and Astrup [37] modiﬁed by Baldo and colleagues [38].
Brieﬂy, petri dishes containing a ﬁbrin-agarose gel were prepared
from a mixture of 3 mg/mL human ﬁbrinogen (SIGMA) with 2%
agarose in 50 mM Tris/HCl pH 7.3 buffer containing 200 mM NaCl,
50 mM CaCl2 and 2 U/mL thrombin. Venom or isolated SVMPs were
diluted to different concentrations in 50 mL of PBS and applied to
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37 C for 18 h, and the halo of hydrolysis was measured as the area
of the circle showing ﬁbrin lysis subtracting the area of the circular
oriﬁce used for sample application. Results are expressed as
mean ± SD of the hydrolysis area corresponding to the ﬁbrinolytic
activity (cm2) from three independent experiments.2.11. Pro-coagulant activity
The coagulant activity of venom pools was assessed in citrated
human plasma from healthy donors. Venom or isolated SVMPs
were diluted to different concentrations in 25 mL of PBS, incubated
with 100 mL of plasma at 37 C and the clotting time measured in a
coagulometer (Diagnostica Stago, START 4). Three independent
experiments were performed in triplicate and results are expressed
as mean ± SD of the 9 obtained values.2.12. Platelet aggregation assay
The effect of the SVMPs on collagen-induced platelet-aggrega-
tion was accessed in washed human platelets obtained as previ-
ously described [39]. For the experiments, samples containing
different amounts of isolated SVMPs diluted in 100 mL Tyrode's
buffer were added to 400 mL of washed platelets 3 min before the
addition of collagen (2 mg/mL). The light transmission was moni-
tored in an aggregometer (CHRONO-LOG Corporation/490 2D),
calibrated to 100% transmittance with Tyrode's solution and 0%
transmittance with washed platelets. Inhibition was estimated by
the decrease in light transmission.2.13. Statistical analysis
Analysis of Variance (ANOVA) One-Way was used followed by
Tukey post-test (for multiple comparisons). The level of signiﬁ-
cance was set at p  0.05.Fig. 1. Elution proﬁles of venoms from wild or captive B. atrox snakes. Samples of 2 mg of
500 mL of triﬂuoroacetic acid (TFA) 0.1% and subjected to reverse-phase chromatography on
TFA in water (solution A) and acetonitrile (solution B) as indicated by the dotted line. Peak3. Results
3.1. Comparison of chromatographic proﬁles and major toxic
activities of the whole venoms
Pools of B. atrox venoms obtained from snakes collected in the
natural environment or maintained under captivity were ﬁrst
compared according to the elution proﬁle of their constituents in
C-18 reverse phase HPLC chromatographies. As shown in Fig. 1, the
chromatographic proﬁle of venoms extracted from wild or captive
snakes were similar and comparable to the proﬁles already
described in the literature for B. atrox from different regions of
Brazilian Amazon [15,20]. In both cases, the predominant peaks
were eluted in the latest periods of the chromatography (after
85 min) which corresponded mostly to PIII-SVMPs. However, some
differences between peak areas were also noted, especially at
elution times from 50 to 85 min (Fig. 1). At the elution times of
approximately 55, 66, 70, 76 and 84 min, the chromatogram of the
venom fromwild snakes showed peaks with greater areas (Fig. 1 e
*). According to the previous data, peak eluted at 55 min corre-
sponds to K-49 PLA2 and the other peaks include mixtures of D-49
PLA2, PI-SVMPs and SVSPs [15,20]. Thus, our next step was to
compare the most important venom biological activities related to
these components. The comparison of hemorrhagic, ﬁbrinolytic,
pro-coagulant and myotoxic activities of venom pools from wild
and captive snakes is shown in Fig. 2. Both venoms showed similar
hemorrhagic activities (MHD of 2.31 mg, wild, and 2.25 mg, captivity)
and the values did not differ signiﬁcantly in any tested doses
(Fig. 2A). Statistically signiﬁcant differences between ﬁbrinolytic
activity of the pools were observed in concentrations of 2, 5 and
10 mg/50 mL being 10e20% higher in venoms of captive snakes
(Fig. 2B). Higher coagulant activity was also detected in the pool of
venom from captive snakes as the minimal concentration of toxin
that induced coagulation of citrated human plasma in 60 s was
7.97 mg/mL for wild snakes and 3.52 for captive (Fig. 2C). The
myotoxic activity of the venoms was evaluated by assaying the
enzyme creatine kinase in the sera of mice injected with 50 and
100 mg/50 mL PBS of both pools. The resulting CK values of both
pools were not statistically different than the group that received
PBS alone (Fig. 2D), suggesting that myotoxicity is not a major
characteristic of B. atrox venom. According to these results, wepools of venoms from wild (gray line) or captive (black line) snakes were dissolved in
HPLC C18 column. Fractions were eluted at ﬂow rate of 2 mL/min in a gradient of 0.1%
s with distinct areas are indicated (*).
Fig. 2. Biological activities of venoms fromwild or captive B. atrox snakes. Samples of venoms fromwild (-) or captive (:)B. atrox snakes were tested for hemorrhagic activity (A),
ﬁbrinolytic activity (B), coagulant activity (C) and myotoxic activity (D) as described in Material and Methods. Results are expressed as mean ± SD and represent three independent
experiments. *p  0.05.
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tivities. Increments in protein abundance, reﬂected by peak area,
were observed in low-expressed D-49 PLA2, PI-SVMP and SVSP
toxins in the venom of wild snakes, suggesting that ﬁbrinolytic and
coagulant activities should be higher in such venoms. However, the
opposite was observed with lower levels of ﬁbrinolytic and coag-
ulant activities in the same pool of venom. This evidence suggests
that increases in toxin abundance observed in venoms of wild
snakes do not correlate with biological activities and that other
toxins may be responsible for the light increase in biological ac-
tivities observed in venoms of captive snakes.3.2. Puriﬁcation of SVMPs
The next step was to isolate the predominant toxin from each
pool of venom to perform a structural and functional character-
ization. PIII-SVMPs were puriﬁed independently from both pools of
venoms using hydrophobic interaction and anion exchange col-
umn, as shown in Fig. 3. The steps of puriﬁcation were monitored
by SDS-PAGE and hemorrhagic activity and positive fractions are
indicated in the ﬁgure by the line under the peak. Chromatographic
procedures of both pools resulted in very similar elution proﬁles. In
the hydrophobic interaction (Fig. 3A and D), venoms were frac-
tionated in fourmajor peaks. When 10 mg of each fraction from both
pools were injected into mice, peaks 1 and 2 induced small spots of
hemorrhage while peaks 3 and 4 induced hemorrhagic spots
similar to the same dose of venom. However, only in fractions
corresponding to peak 4 the relative molecular masses were
consistent with PIII-SVMPs. The next step of puriﬁcation was per-
formed by anion exchange chromatography (Fig. 3B and E). The
chromatographic proﬁles were again very similar between the
pools. The chromatograms showed two major peaks, one with the
proteins that did not interact with the stationary phase, completely
devoid of hemorrhagic activity, and the other eluted atapproximately 150mMNaCl of the elution gradient. The latter peak
(P2) retained hemorrhagic activity, which was further quantiﬁed
and compared to whole venom as MHD, and was tested for purity
and stability. The electrophoretic proﬁle of P2 showed a band with
relative molecular mass of 50 kDa under non-reducing conditions.
Under reducing conditions, a band around 30 kDawas also detected
to the proﬁle of the isolated protein from both pools (Fig. 3C and F).
Some PIII-class SVMPs undergo autolysis in vitro generating a
fragment of approximately 30 kDa, which corresponds to the dis-
integrin-like⁄cysteine-rich domains [27], suggesting that the iso-
lated SVMPs also underwent autolysis. To test this hypothesis,
samples were incubated for 24 hs at 37 C and subjected to SDS-
PAGE. As can be seen in Fig. 3C and F, a band of approximately
30 kDa and also a smear below 50 kDa increased over the time
under reducing conditions. This was the same autolytic pattern
observed earlier in autolysis experiments with jararhagin in which
the 30 kDa fragment corresponded to the disintegrin-like⁄cysteine-
rich domain that remained linked to the catalytic domain by a di-
sulﬁde bond and a fragment of approximately 48 kDa that appeared
as result of cleavage of the N-terminal portion of the enzyme [27].
The bands of 30 kDa were cut out and analyzed by mass spec-
trometry. The peptides identiﬁed from captivity and natural envi-
ronment SVMPs corresponded to regions of the disintegrin-like⁄
cysteine-rich domain conﬁrming the autolysis of B. atrox SVMPs
(data not shown).3.3. Primary structure characterization of B. atrox SVMPs
The primary structure of the isolated proteins was carried out by
mass spectrometry of tryptic peptides obtained from the 50 kDa
band excised from the gels (Fig. 3*). Peptide identiﬁcation was
achieved by searching in a transcriptomic database constructed by
RNA-seq from venom glands of 5 specimens collected in their
natural environment at Para State, Brazil. Supplementary Table 1
Fig. 3. Puriﬁcation of PIII-SVMPs from venoms fromwild or captive B. atrox snakes. Samples of 86 mg of venoms from captive (A, B, C) or wild (D, E, F) B. atrox snakes were applied
on Hitrap Phenyl FF low sub column (A, D) and eluted with a gradient of 20 mM Tris/HCl buffer, pH 6.8, containing 1.2 M (NH4)2SO4 (solution A) to Tris buffer without (NH4)2SO4
(solution B) as indicated by dotted line. Fractions containing bands of ~50 kDa and hemorrhagic activity (continuous line under the peaks) were applied to a Mono Q™ column (B, E),
and eluted with a gradient from 0 to 1 M NaCl as indicated by dotted line at a ﬂow rate of 1 mL/min, monitored at UV280nm. Fractions indicated in the graphs B and E by continuous
line under the peak were subjected to SDS-PAGE (C, F) under non-reducing conditions (NR) or reducing conditions (R) as obtained from the chromatography (T0) or after incubation
at 37 C for 24 h (T 24). Bands with molecular masses correspondent to PIII-SVMPs (*) were excised from the gels and subjected to MS/MS.
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complete cDNA and putative protein sequence highlighting the
peptides identiﬁed by MS/MS from wild snakes SVMPs (shadowed
in gray) or from snakes kept under captivity (boxes). As can be seen,
fragments from both SVMPs perfectly aligned with a transcript of a
PIII-class SVMP that encodes a classical P-IIIb representative of
these enzymes. Also, the data revealed that the toxins isolated from
venoms fromwild or captive snakes are identical: The pre- and pro-
domains of 189 residues, containing the cysteine-switch motif
(residues 26 to 20) followed by the characteristic glutamic acid
that corresponds to the N-terminal of the mature PIII-SVMPs and is
predicted to be post-translation modiﬁcated to pyroglutamic. The
catalytic domain contains the zinc-binding motif and the met-turn
structure (residues 145 to 154 and 167 to 169, respectively) that
assure its catalytic properties. The C-terminal domains are the
typical disintegrin-like/cysteine-rich domains with the motif
SECDPA (residues 274 to 279) replacing the RGD found in the
typical disintegrins. Considering the hemorrhagic activity of the
isolated proteins and the coverage of approximately 50% with the
cDNA, this sequence was named Batroxrhagin and represents the
major PIII-class SVMP from B. atrox venom from wild and captive
snakes.
Batroxrhagin sequence was then compared with other SVMPs
and the alignment of sequences from different species of vipers is
shown in Fig. 5. The highest hit on a Blast search (96% identity) was
with Jararhagin, isolated from B. jararaca venom [26], followed by
identities above 90% with other SVMPs from Bothrops snakes:
Bothropasin, from B. jararaca venom [40] and an SVMP character-
ized in Bothrops insularis transcriptome [41]. High levels of identity
were also observed with SVMPs from different genera of vipers.
Identity of 88% was achieved with Brevilysin H6 [42] from Gloydius
halys brevicaudus, 87% with Catrocollastatin [43] from Crotalus
atrox and 85% with Acuhagin [44] from Agkistrodon acutus venoms.Interestingly, the identity with Batroxtatin 1, Batroxtatin 2 and
Batroxtatin 3, other PIII-SVMPs described from a transcriptome of
B. atrox venom glands [45] was below 60%, conﬁrming the struc-
tural variability among this group of toxins. Batroxtatin sequences
have never been isolated from the venom suggesting that they may
correspond to minor components not detected under our puriﬁ-
cation protocol.
3.4. Biological activity of Batroxrhagin
Major biological activities of PIII-SVMPs were then compared
between Batroxrhagin isolated from venom of snakes obtained in
the natural environment or kept under captivity (Fig. 6). There was
no signiﬁcant difference between hemorrhagic or ﬁbrinolytic ac-
tivities of SVMPs in venoms from both pools and their MHD were
very similar 1.43 and 1.24 mg, respectively (Fig. 6A). Both SVMPs
were capable of similarly hydrolyzing ﬁbrin in a dose-dependent
manner (Fig. 6B) and inhibited collagen-dependent platelet-ag-
gregation (Fig. 6C).
4. Discussion
The analysis of variability in the composition of snake venoms is
a recurring theme among toxinologists. Besides the relevance of the
issue for understanding snake ecology and evolution, comprehen-
sive studies comparing toxin composition and functional variability
of venoms from snakes kept under captivity or collected at the
natural environment are of fundamental importance in order to
obtain effective antivenoms. The production of Bothrops anti-
venoms in Brazil depends on the immunization of horses with
controlled pools of venoms extracted from ﬁve species of captive
breed snakes feed by rodents [46]. As a consequence, antibodies
present in the antivenoms are directed to the toxins used in the
Fig. 4. Batroxrhagin cDNA and protein sequences. Batroxrhagin cDNA and putative
protein sequences were retrieved from a transcriptome database obtained by RNA
sequencing from venom glands of 5 specimens of B. atrox collected at the natural
environment in Para State, Brazil. Peptides identiﬁed by MS/MS in wild snakes isolated
SVMPs ( ) or captive snakes SVMPs (▫) are evidenced in the ﬁgure. Numberings are
according to the putative N-terminal residue of the mature protein for amino acids ( )
and for the initiation ATG codon for nucleotides. Lower case letters correspond to the
50 and 30 untranslated regions. Functional motifs corresponding to the cysteine-switch,
zinc-binding and collagen-binding motives, respectively, are in bold and underlined.
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tion of toxins present in venoms of the other species of Bothrops
snakes present on different environments. In spite of the medical
relevance, the variability in venom composition due to environ-
mental changes when snakes are introduced to captivity has not
been widely studied. Toxic effects resulting from such variation arestill poorly known and the data available in the literature is not
conclusive.
The variation in the composition of venoms after introducing
the snakes to controlled environment was analyzed by Gregory-
Dwyer and collaborators [47]. The authors compared three spe-
cies of Crotalus housed under the same temperature and light
conditions and fed on the same diet for 20 months; they observed
little changes in the electrofocusing patterns of the venoms, sug-
gesting that interspeciﬁc variation is genetically inherited instead
of experimentally induced. In addition, Modahl and collaborators
[48] compared venoms obtained from 15 specimens of Naja naja
under long term captivity, observing differences in concentrations
of different toxins, particularly less abundant venom components.
However, in the study of Gibbs and collaborators [5] with adult
females of Sistrurus barbouri miliarius, a signiﬁcant increase in the
relative abundance of the major classes of toxins was observed on
snakes fed only with mice compared to the ones fed on lizards or
frogs (similar to natural diet). In our study, we compared the
composition and biological activities of venoms from B. atrox
snakes collected at Tapajos National Forest (Para State, Brazil) or
maintained for more than 10 years under captivity at Instituto
Butantan herpetarium after they have been collected mostly at
Maranh~ao State, Brazil. B. atrox venom is a good model to analyze
changes in venom composition due to environmental factors.
Several previous studies have shown that this venom undergoes
high variability in its composition due to geographical or ontoge-
netic conditions [15,16] and, despite the fact that it is not included
in the immunization pool, it is well recognized and neutralized by
the commercial antivenom [20].
Pools of B. atrox venomwere compared according to the elution
proﬁle of their constituents by C-18 reverse phase HPLC chroma-
tography. This method is used in several venomics studies
[15,16,20,49,50], what allows the inference of protein composition
in each chromatographic peak by comparison with proteomic data
available in the literature. Our results show a great similarity in the
chromatographic proﬁle of B. atrox venom from wild and captive
snakes except for quantitative differences in the area of small peaks
eluted at the same positions as K-49 PLA2, D-49 PLA2, PI-SVMPs and
SVSPs, higher in venoms of wild snakes, suggesting that the
expression of these proteins, although in lower concentrations in
the venom, suffer the greatest effect environmental changes.
Furthermore, signiﬁcant differences have been detected in ﬁbri-
nolytic and coagulant activities, higher in the pool of venoms from
captive snakes. This evidence suggests that increases in toxin
abundance observed in venoms of wild snakes do not correlate
with biological activities and that other toxins may be responsible
for the light increase in biological activities observed in venoms of
captive snakes. On the other hand, the magnitude of those differ-
ences was small and hardly may affect antivenom production.
This study also reiterates the importance of PIII-SVMPs in
B. atrox venom composition. The major peaks in venom chroma-
tography of both pools eluted at the same position of B. atrox PIII-
SVMPs reported in previous studies [15,16,20]. However, in these
studies PIII-SVMPs were characterized at the protein family level
and the proteoform expressed in each sample was not character-
ized. The literature describes the isolation of several PI-SVMPs from
B. atrox venom as atroxlysin-I [51], batroxase [52] and Batx-I [53].
Only one PIII-SVMP has been isolated [54], however, its structural
characterization was partial and the results did not address the
major functional activities of this class of toxin. In this context, we
decided to isolate the predominant PIII-SVMP from both pools,
what resulted in two protein samples with exactly the same pri-
mary structure and toxic activity, which we named Batroxrhagin.
For puriﬁcation of Batroxrhagin several methods were tested, but
only themethod used to purify jararhaginwas shown to be efﬁcient
Fig. 5. Sequence alignment of Batroxhagin sequence with other PIII-SVMPs from different species of viper snakes. Deduced amino acid sequence of Batroxrhagin (KR632593) was
aligned with jararhagin (P30431), from B. jararaca venom, Acurhagin (Q9W6M5), from Agkistrodon acutus venom, Catrocollastatin (Q90282), from Crotalus atrox venom, Brevilysin
(P0C7B0), from Gloydius halys brevicaudus venom and Batroxtatin-1 (EU733639), Batroxtatin-2 (EU733640) and Batroxtatin-3 (EU733641) from Bothrops atrox venom. Sequences
were aligned using ClustalW at web.expasy.org and dots indicate identical residues to the ﬁrst sequence.
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Batroxrhagin with Jararhagin. These observations indicate that the
overall composition of B. atrox venom is similar to B. jararaca
venom with a well conserved hemorrhagic PIII-SVMP as the most
abundant toxin.
Batroxrhagin was able to hydrolyze ﬁbrin and was highly
hemorrhagic as other PIII-SVMPs described in the literature
[26,55,56]. The hemorrhagic process triggered in the envenomation
is directly related to the degradation of basement membrane, cell
surface and plasma proteins due to catalytic properties of SVMPs
[22,23]. Baldo and collaborators [57] demonstrated that a particulartissue accumulation of jararhagin in the basement membrane is
essential for the damage of the blood vessels and suggested that
this accumulation is due to the binding of the toxin to collagen. The
importance of collagen binding for triggering the hemorrhagic ac-
tion of PIII-SVMPwas also suggested by Tanjoni and colleagues [58]
using antibodies that blocked the binding of jararhagin to collagen
and also abolished hemorrhagic activity. Thus the particular accu-
mulation PIII-SVMP in the capillary vessels through adhesive
properties of non-enzymatic domains allows hydrolysis of the
components of the basement membrane and consequent extrava-
sation of blood [57]. Adding to the catalytic properties,
Fig. 6. Biological activities of PIII-SVMPs isolated from venoms fromwild or captive B. atrox snakes. Different concentrations of SVMPs isolated from venoms of wild (-) or captive
(:) B. atrox snakes were tested for hemorrhagic (A) and ﬁbrinolytic activities (B) as described in Material and Methods. Results are expressed as mean ± SD and represent three
independent experiments; *p  0.05. SVMPs were also tested for inhibition of collagen-induced platelet-aggregation at concentration of 50 mg/mL (C). Graphics show the increase in
light transmission due to platelet aggregation after challenge with 2 mg/mL collagen. Results are representative of three independent experiments.
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aggregation. Platelets are known as a target of SVMPs in the
disturbance of hemostasis, and most of PIII-SVMPs already char-
acterized are able to inhibit aggregation of platelets induced by
collagen [59]. One mechanism explaining PIII-SVMP inhibition of
collagen-induced platelet-aggregation is the interaction of the
toxin either with the integrin a2b1 [59,60] or to collagen [39] by a
conformational motif in the C-terminal portion the disintegrin-like
domain [61] or via structural motifs present in the cysteine-rich
domain [62]. The two regions were covered in Batroxrhagin
sequencing and were identical to the counterpart regions in jar-
arhagin. In this way, Batroxrhagin is contributing to the hemostatic
disturbances induced by B. atrox venom and accordingly to the
structural identity with jararhagin, we suggest that this SVMP is
also playing important role in the pro-inﬂammatory and local ef-
fects of the venom. One particular feature identiﬁed in Batroxrha-
gin is its great potential to undergo autolysis. Petretski and
collaborators [54] identiﬁed a PIII-SVMP from B. atrox venom that
undergoes a spontaneous degradation process and releases a
fragment around 26 kDa identiﬁed as disintegrin-like⁄cysteine-rich
domains. In addition to this work, Lopes-Lozano and collaborators
[17] demonstrated the presence of three isoforms of a PIII-SVMP in
B. atrox venomwhich also undergo autolysis to generate a fragment
of 27 kDa. Batroxrhagin also maintained the characteristic of other
PIII-SVMPs isolated from the same venom. Possibly, thesemolecules are the same. However, the sequence identiﬁcation of
the previously isolated proteins was partial and does not allow
their identiﬁcation at structural level.
5. Conclusions
The ﬁndings here exposed reinforce the previous data [15,20]
showing that the PIII-SVMPs are the predominant antigens in
venoms of Brazilian B. atrox snakes and indicate that, at least in
Brazil, venom of B. atrox snakes show variability on the composition
of their toxins but such variability is related to the less abundant
venom components and reﬂects only in slight quantitative differ-
ences in venom activities. The characterization of Batroxrhagin as
the major antigen, its high conservation in the venom pools and
strong similarity with jararhagin explain the efﬁcacy of antivenoms
in neutralize the major effects of human symptoms following
snakebite and assure the possibility of using long term captivity
snakes for antivenom production.
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